{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:02:51Z","timestamp":1794121371220,"version":"4.8.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alcon Research Ltd"},{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajo.2019.07.015","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:53:58Z","timestamp":1564689238000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study"],"prefix":"10.1016","volume":"208","author":[{"given":"George","family":"Reiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2019.07.015_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ophtha.2018.02.003","article-title":"Primary tube versus trabeculectomy study group. treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up","volume":"125","author":"Gedde","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2019.07.015_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2006.07.022","article-title":"Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up","volume":"143","author":"Gedde","year":"2007","journal-title":"Am\u00a0J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2019.07.015_bib3","first-page":"571","article-title":"Bleb-related infections and long-term follow-up after trabeculectomy","volume":"39","author":"Luebke","year":"2019","journal-title":"Int\u00a0Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2019.07.015_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ajo.2015.03.001","article-title":"Long-term bleb-related infections after trabeculectomy: incidence, risk factors, and influence of bleb revision","volume":"159","author":"Kim","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.015_bib5","doi-asserted-by":"crossref","first-page":"705915","DOI":"10.1155\/2013\/705915","article-title":"Update on minimally invasive glaucoma surgery (MIGS) and new implants","volume":"2013","author":"Brandao","year":"2013","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.015_bib6","first-page":"189","article-title":"Minimally invasive glaucoma surgery: current status and future prospects","volume":"10","author":"Richter","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2019.07.015_bib7","doi-asserted-by":"crossref","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","article-title":"Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis","volume":"12","author":"Lavia","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ajo.2019.07.015_bib8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ophtha.2016.06.032","article-title":"Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts","volume":"123","author":"Vold","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2019.07.015_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators","volume":"130","author":"The Advanced Glaucoma Intervention Study (AGIS): 7","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2019.07.015_bib10","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the Early Manifest Glaucoma Trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.07.015_bib11","doi-asserted-by":"crossref","unstructured":"Lass JH, Benetz BA, He J, et\u00a0al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass Micro-Stent. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2019.07.016.","DOI":"10.1016\/j.ajo.2019.07.016"},{"key":"10.1016\/j.ajo.2019.07.015_bib13","author":"US Food and Drug Administration"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941930368X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941930368X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:41:58Z","timestamp":1762080118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293941930368X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":12,"alternative-id":["S000293941930368X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2019.07.015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736343673.793564366","asserted-by":"object"}]},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}